Moreover, knockdown of LAMC2 was able to inhibit EGFR phosphorylation as well as its downstream targets ERK and AKT in pancreatic, anaplastic thyroid carcinoma, and gastric cancer cells [11, 18, 35]. This evidence concerns the gene EGFR and gastric cancer.